Is early measles vaccination better than later measles vaccination?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 109, Issue 1, 2014, Pages 16-28

  Aaby, Peter ^a,b   Martinsa, Cesário L ^a   Ravn, Henrik ^b   Rodrigues, Amabelia ^a   Whittle, Hilton C ^c   Benn, Christine S ^a,b  

^a Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^b STATENS SERUM INSTITUT   (Denmark)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Early vaccination; Measles vaccination; Non specific effects

Indexed keywords

MEASLES VACCINE; VIRUS ANTIBODY;

ARTICLE; CAUSE OF DEATH; CHILDHOOD MORTALITY; FOLLOW UP; HUMAN; MEASLES; MEASLES VACCINATION; OBSERVATIONAL STUDY; IMMUNIZATION; IMMUNOLOGY; INFANT; MORTALITY; PASSIVE IMMUNIZATION; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; SURVIVAL; VACCINATION;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; MEASLES; MEASLES VACCINE; SURVIVAL ANALYSIS; VACCINATION;

EID: 84928898888     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru174     Document Type: Article

References (57)

1. Expanded Programme on Immunization. The optimal age for measles immunization. Wkly Epidemiol Rec 1982;57:89-91.
2. De Quadros CA, Izurieta H, Venczel L, Carrasco P. Measles eradication in the Americas: progress to date. J Infect Dis 2004;189(Suppl 1):S227-35.
3. Meeting of the immunization Strategic Advisory Group of experts, November 2006 - conclusions and recommendations. Wkly Epidemiol Rec 2007;82:1-16.
4. Aaby P, Martins CL, Garly ML et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality:randomised controlled trial. BMJ 2010;341:c6495.
5. Aaby P, Samb B, Simondon F et al. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995;311:481-5.
6. Higgins JPT, Soares-Weiser K, Reingold A. Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines. http://www.who.int/immunization/sage/meetings/2014/april [accessed 1 June 2014].
7. Garly ML, Aaby P. The challenge of improving the efficacy of measles vaccine. Acta Trop 2003;85:1-17.
8. Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol 2010;39(Supp 1):i48-i55.
9. FischerWalker CL, Munos MK, Black RE. Quantifying the indirect effects of key child survival interventions for pneumonia, diarrhea, and measles. Epidemiol Infect 2013;141:115-31.
10. Benn CS, Bale C, Sommerfelt H et al. Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines? Int J Epidemiol 2003:32:822-8.
11. Aaby P, Garly ML, Balé C et al. Survival of previously measlesvaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Pediatr Infect Dis J 2003;22:798-805.
12. Aaby P, Garly ML, Jensen H et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanuspertussis vaccines: Observations from vaccination trials in Guinea-Bissau. PIDJ 2007;26:247-52.
13. Garenne M, Cantrelle P. Measles and mortality in Senegal: study of the impact on child survival of vaccinations carried out in Khombole 1965-1968. Paris: INSERM 1986;145:515-32.
14. The Kasongo Project Team. Influence of measles vaccination on survival pattern of 7-35-month-old children in Kasongo, Zaire. Lancet 1981;1:764-7.
15. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984;8:13-21.
16. Holt EA, Boulos R, Halsey NA et al. Childhood survival in Haiti: protective effect of measles vaccination. Pediatrics 1990;86:188-94.
17. Aaby P, Pedersen IR, Knudsen K et al. Child mortality related to seroconversion or lack of seroconversion after measles vaccination. Pediatr Infect Dis J 1989;8:197-200.
18. Velema JP, Alihonou EJ, Gandaho T, Hounye FH. Childhood mortality among users and non- users of primary health care in a rural west African community. Int J EpidemioI 1991;20:474-9.
19. George K, Jospeh A, Muliyil J et al. Measles vaccination before nine months. Trop Med Int Health 1998;3:751-6.
20. Kabir Z, Long J, Reddaiah VP et al. Non-specific effects of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study. Bull World Health Organ 2003;81:244-50.
21. Hirve S, Bavdekar A, Juvekar S et al. Non-specific and sex-differential effects of vaccinations on child survival in rural western India. Vaccine 2012;30:7300-8.
22. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000;321:1435-8.
23. Lehmann D, Vail J, Firth MJ et al. Benefits of routine immunisations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea. Int J Epidemiol 2005;34:138-48.
24. Msamanga GI. A prospective study of measles immunization in relation to the risk of measles incidence and mortality in Tanzania. PhD Thesis. Boston: Harvard University; 1990.
25. Clemens JD, Stanton BF, Chakraborty J et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988;128:1330-9.
26. Koenig MA, Khan MA,Wojtyniak B et al. Impact of measles vaccination upon childhood mortality in rural Bangladesh. BullWorld Health Organ 1990;68:441-7.
27. Aaby P, Bhuyia A, Nahar L et al. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol 2003;32:106-16.
28. Breiman RF, Streatfield PK, Phelan M et al. Effect of infant immunization on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data. Lancet 2004;364:2204-11.
29. Aaby P, Vessari H, Nielsen J et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 2006;25:721-7.
30. Aaby P, Samb B, Simondon F et al. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. Am J Epidemiol 1993;138:746-55.
31. Elguero E, Simondon KB, Vaugelade J et al. Non-specific effects of vaccination on survival: A prospective study in Senegal. Trop Med Int Health 2005;10:956-60.
32. Aaby P, Nielsen J, Benn CS, Trape JF. Sex-differential and non-targeted effects of routine vaccinations in a rural area with low vaccination coverage: Observational study from Senegal. Trans R Soc Trop Med 2015;109:77-84.
33. Kapoor SK, Reddaiah VP. Effectiveness of measles immunization on diarrhea and malnutrition related mortality in 1-4 year olds. Indian J Pediatr 1991;58:821-3.
34. Desgrées du Loû A, Pison G, Aaby P. The role of immunizations in the recent decline in childhood mortality and the changes in the female/malemortality ratio in rural Senegal. AmJ Epidemiol 1995;142:643-52.
35. Bawah AA, Phillips JF, Adjuik M et al. The impact of immunization on the association between poverty and child survival: Evidence from Kassena-Nankana District of northern Ghana. Scand J Pub Health 2010;38:95-103.
36. Nyarko P, Pence B, Debpuur C. Immunization status and child survival in rural Ghana. Working papers No. 147. New York: Population Council; 2001.
37. Farrington CP, Firth MJ, Moulton LH et al. Epidemiological studies of the non-specific effects of vaccines: II - methodological issues in the design and analysis of cohort studies. Trop Med Int Health 2009;14:977-85.
38. Aaby P, Benn CS, Nielsen J, Ravn H. Sex-differential non-specific effects of BCG and DTP in Cebu, The Philippines. Int J Epidemiol 2009:38:320-3.
39. Aaby P, Benn CS, Nielsen J et al. DTP vaccination and child survival in observational studies with incomplete vaccination data. Trop Med Int Health 2007;12:15-24.
40. Aaby P, Benn CS, Nielsen J et al. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012;2:e000707.
41. Jensen H, Benn CS, Lisse IM et al. Survival bias in observational studies of the impact of routine vaccinations on childhood survival. Trop Med Int Health 2007;12:5-14.
42. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect:non-specific immunomodulation by vaccines. Trends Immunol 2013;34:431-9.
43. Kleinnijenhuis J, Quintin J, Preijers F et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012;109:17537-42.
44. Fisker AB, Bale C, Rodrigues A et al. A randomised trial of high-dose vitamin A at vaccination contacts after 6 months of age. Pediatrics 2015 [forthcoming].
45. Martins CL, Benn CS, Andersen A et al. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. J Infect Dis 2014;209;1731-8.
46. Aaby P, Jensen H, Samb B, Cisse B et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003;361:2183-8.
47. de Quadros CA. Can measles be eradicated globally? BullWorld Health Organ 2004;82:134-8.
48. Aaby P, Andersen M, Sodemann M et al. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. BMJ 1993;307:1308-11.
49. Aaby P, Martins CL, Garly ML et al. Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clin Infect Dis 2014;59:484-92.
50. Navarini AA, Krzyzowsko M, Lang KS et al. Long-lasting immunity by early infection of maternal antibody-protected infants. Eur J Immunol 2010;40:113-6.
51. Crowe JE, Bui PT, Siber GR et al. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine 1995;13:847-55.
52. Sandbulte MR, Platt R, Roth JA et al. Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies. Virology 2014;464-465:45-54.
53. Martins CL, Garly ML, Balé C et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months:interim analysis of a randomised clinical trial. BMJ 2008;337:a661.
54. Njie-Jobe J, Nyamweya S, Miles DJ et al. Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years. Vaccine 2012;30:2543-50.
55. Martins C, Garly ML, Bale C et al. Measles antibodies responses after an early two dose schedule with edmonston-zagreb standard-titre measles vaccine at 4.5 and 9 months of age. J Infect Dis 2014;210:693-700.
56. Aaby P, Martins CL, Garly ML et al. The optimal age of measles immunization in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open 2012;2:e000761.
57. Sørup S, Benn CS, Poulsen A et al. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA 2014;311:826-35.